|
US4090021A
(en)
*
|
1971-10-08 |
1978-05-16 |
Schering Aktiengesellschaft |
Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
|
|
DE2508312A1
(de)
*
|
1975-02-24 |
1976-09-02 |
Schering Ag |
Neues verfahren zur herstellung von nucleosiden
|
|
DE2514275A1
(de)
*
|
1975-03-27 |
1976-10-14 |
Schering Ag |
Verfahren zur herstellung von n- (polysaccharidyl)-stickstoffheterocyclen, insbesondere von pyrimidin- oder purinbasen
|
|
US4118484A
(en)
*
|
1976-03-29 |
1978-10-03 |
The Upjohn Company |
Method of treating rheumatoid arthritis
|
|
DE2621645C3
(de)
*
|
1976-05-13 |
1981-08-06 |
Schering Ag Berlin Und Bergkamen, 1000 Berlin |
Verfahren zur Herstellung von Aminoderivaten von N-Heterocyclen
|
|
GB1601020A
(en)
|
1978-04-24 |
1981-10-21 |
Stichting Grega Vzw |
2'-deoxy-5 (2-halogenovinyl)-uridines
|
|
US4267171A
(en)
*
|
1979-07-02 |
1981-05-12 |
The Regents Of The University Of California |
C-5 Substituted cytosine nucleosides
|
|
US4754026A
(en)
*
|
1985-06-04 |
1988-06-28 |
Takeda Chemical Industries, Ltd. |
Conversion of uracil derivatives to cytosine derivatives
|
|
FR2590255B1
(fr)
*
|
1985-11-19 |
1987-12-24 |
Rhone Poulenc Sante |
Procede de preparation de derives de la pteridine
|
|
US4788181A
(en)
*
|
1986-09-29 |
1988-11-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
|
|
US6432924B1
(en)
|
1993-12-26 |
2002-08-13 |
East Carolina University |
Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
|
|
US6974666B1
(en)
*
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
|
CA2241255A1
(en)
*
|
1995-12-22 |
1997-07-03 |
East Carolina University |
Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
|
|
US6965020B2
(en)
|
1996-01-23 |
2005-11-15 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
|
US7282327B2
(en)
*
|
1996-01-23 |
2007-10-16 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
|
US6864059B2
(en)
*
|
1996-01-23 |
2005-03-08 |
Affymetrix, Inc. |
Biotin containing C-glycoside nucleic acid labeling compounds
|
|
US20010018514A1
(en)
*
|
1998-07-31 |
2001-08-30 |
Mcgall Glenn H. |
Nucleic acid labeling compounds
|
|
US20040210045A1
(en)
*
|
1996-01-23 |
2004-10-21 |
Mcgall Glenn |
Nucleic acid labeling compounds
|
|
EP0880598A4
(en)
*
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
|
US7291463B2
(en)
*
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
|
US7423143B2
(en)
*
|
1996-01-23 |
2008-09-09 |
Affymetrix. Inc. |
Nucleic acid labeling compounds
|
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
EP1294735A2
(en)
|
2000-05-26 |
2003-03-26 |
Novirio Pharmaceuticals Limited |
Methods and compositions for treating flaviviruses and pestiviruses
|
|
US20030008841A1
(en)
*
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
|
WO2002072779A2
(en)
|
2001-03-12 |
2002-09-19 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
|
US7662798B2
(en)
*
|
2002-06-28 |
2010-02-16 |
Idenix Pharmaceuticals, Inc. |
2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
US7608600B2
(en)
*
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
PL377342A1
(pl)
|
2002-11-15 |
2006-01-23 |
Idenix (Cayman) Limited |
Nukleozydy rozgałęzione w pozycji 2' oraz mutacja Flaviviridae
|
|
MXPA05006230A
(es)
|
2002-12-12 |
2005-09-20 |
Idenix Cayman Ltd |
Proceso para la produccion de nucleosidos ramificados-2'.
|
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
|
US7038038B2
(en)
*
|
2003-03-17 |
2006-05-02 |
Pharmion Corporation |
Synthesis of 5-azacytidine
|
|
US6887855B2
(en)
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
|
BRPI0408561A
(pt)
*
|
2003-03-20 |
2006-03-21 |
Microbiol Quimica Farmaceutica |
métodos para manufatura de 2'-desoxi-59-l-nucleosìeos
|
|
WO2004096149A2
(en)
|
2003-04-28 |
2004-11-11 |
Idenix (Cayman) Limited |
Industrially scalable nucleoside synthesis
|
|
EP2157095A3
(en)
*
|
2003-06-30 |
2010-09-08 |
Novartis AG |
Synthesis of beta-L-2-Deoxy nucleosides
|
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
|
JP5254033B2
(ja)
|
2005-12-23 |
2013-08-07 |
イデニク プハルマセウティカルス，インコーポレイテッド |
分岐型ヌクレオシドを調製するための合成中間体の製造方法
|
|
CN101815437A
(zh)
*
|
2007-09-26 |
2010-08-25 |
辛乃山医学院 |
氮杂胞苷类似物和其应用
|
|
LT3692983T
(lt)
*
|
2008-05-15 |
2021-11-10 |
Celgene Corporation |
Citidino analogų peroralinės kompozicijos ir jų naudojimo būdai
|
|
BR112013025167A2
(pt)
|
2011-03-31 |
2019-09-24 |
Celgene Int Sarl |
processo para preparar 5-azacitidina, ou um sal, solvato, hidrato, ou seu polimorfo, sal de 5-azacitidina, 5-azacitidina, ou um sal, solvato, hidrato, ou polimorfo
|